Clinical Trial Update: Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer [NA]

View source ↗

Summary

A clinical trial is evaluating a liposomal irinotecan combination as first-line therapy for small cell lung cancer, with the study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Liposomal irinotecan (liposomal irinotecan)

Snippet

Sponsor: Zhou Chengzhi | Conditions: Small Cell Lung Cancer | NA | Status: NOT_YET_RECRUITING